AlzeCure Pharma AB is a pharmaceutical research company. It engages in the development of drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The firm is developing parallel drug candidates based on the research platforms, such as NeuroRestore, Alzstatin, and Painless. The company was founded by Johan Sandin, Gunnar Nordvall, Pontus Forsell, Johan Lundkvist, and Magnus Halldin on November 22, 2016 and is headquartered in Huddinge, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company